The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence of first and subsequent skeletal-related events (SREs) in U.S. elderly patients with metastatic prostate cancer (mPC).
Arif Hussain
Research Funding - Amgen
Abdulla M. Abdulhalim
No relevant relationships to disclose
C. Daniel Mullins
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Novartis; Pfizer
Honoraria - Celgene
Research Funding - Amgen; Bayer; Pfizer
Yi Qian
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jorge Arellano
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Arun Balakumaran
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Research Funding - Amgen
Ebere Onukwugha
Consultant or Advisory Role - Janssen
Honoraria - IMS Health
Research Funding - Amgen; Bayer